Concepedia

Ying‐Ling Chiang

YC

Statistics

Publications

10

Citations

701

H-Index

10

Active since

2002

Affiliations

Cornell University(Current)

Howard Hughes Medical Institute

Novartis (China)

Genomics Institute of the Novartis Research Foundation

Novartis (United States)

Ying‐Ling Chiang is an author at Cornell University specializing in medicine, natural sciences, and cell biology.

ORCID

Top concepts

Publications per year

2002–2023

10

Publications

10

A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity

Hui Jing, Jing Hu, Bin He et al. · Cancer Cell · 2016 · 222 citations · Full text

, , +7

Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis

Meng Li, Ying‐Ling Chiang, Costas A. Lyssiotis et al. · Cancer Cell · 2019 · 147 citations · Full text

Design and Synthesis of Class-Selective Activity Probes for Protein Tyrosine Phosphatases

Lee‐Chiang Lo, Te-Ling Pang, Chi‐Hsien Kuo et al. · Journal of Proteome Research · 2002 · 111 citations

Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer

Yashira L. Negrón Abril, Irma Fernández, Jun Young Hong et al. · Oncogene · 2021 · 80 citations · Full text

, , +8

Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC Interaction

Jian Ding, Guo Li, Hejun Liu et al. · ACS Chemical Biology · 2023 · 38 citations

, , +16

1–5 of 10